Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients
Summary
Third Opinion Trial Synopsis:
This is a medical study for testing a new treatment, where all participants will get the treatment. It will also include a safety check phase to make sure it's safe.
This is a medical study for testing a new treatment, where all participants will get the treatment. It will also include a safety check phase to make sure it's safe.
*Third Opinion AI Generated Synopsis
Trial Summary
This is a single-arm, open-label phase II study with a safety lead-in phase.
This is a single-arm, open-label phase II study with a safety lead-in phase.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: